First Horizon Corporation’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.9K Buy
1,163
+223
+24% +$5.93K ﹤0.01% 839
2026
Q1
$25.2K Sell
940
-16
-2% -$479 ﹤0.01% 828
2025
Q4
$29.4K Buy
956
+277
+41% +$8.63K ﹤0.01% 837
2025
Q3
$20.8K Buy
+679
New +$16.5K ﹤0.01% 853
2021
Q2
$54K Hold
1,323
﹤0.01% 369
2021
Q1
$43K Sell
1,323
-204
-13% -$7.67K ﹤0.01% 395
2020
Q4
$62K Buy
1,527
+159
+12% +$5.94K 0.01% 352
2020
Q3
$50K Buy
+1,368
New +$49.5K 0.01% 356

Other funds holding GMAB

First Horizon Corporation's GMAB Position: Q2 2026 in Review

First Horizon Corporation increased its Genmab (GMAB) stake by 24% in Q2 2026, buying an estimated $5.93K and bringing the position to 1,163 shares worth $31.9K. The position accounts for ﹤0.01% of the portfolio, ranked #839.

First Horizon Corporation first reported a position in GMAB in Q3 2020 and has held it in 8 quarters since. The position peaked at $62K in Q4 2020. 88 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • First Horizon Corporation held 1,163 shares of Genmab worth $31.9K as of Q2 2026.
  • First Horizon Corporation bought 223 Genmab shares in Q2 2026, an estimated $5.93K.
  • Genmab made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #839 holding.
  • First Horizon Corporation first reported a position in Genmab in Q3 2020 and has held it in 8 quarters since.
  • First Horizon Corporation's Genmab position peaked at $62K in Q4 2020.
  • 88 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.